1. Home
  2. SJ vs LPTX Comparison

SJ vs LPTX Comparison

Compare SJ & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SJ
  • LPTX
  • Stock Information
  • Founded
  • SJ 2011
  • LPTX 2011
  • Country
  • SJ China
  • LPTX United States
  • Employees
  • SJ N/A
  • LPTX N/A
  • Industry
  • SJ EDP Services
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SJ Technology
  • LPTX Health Care
  • Exchange
  • SJ Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • SJ 32.0M
  • LPTX 35.4M
  • IPO Year
  • SJ N/A
  • LPTX N/A
  • Fundamental
  • Price
  • SJ $0.54
  • LPTX $0.55
  • Analyst Decision
  • SJ
  • LPTX Hold
  • Analyst Count
  • SJ 0
  • LPTX 1
  • Target Price
  • SJ N/A
  • LPTX N/A
  • AVG Volume (30 Days)
  • SJ 98.2K
  • LPTX 7.9M
  • Earning Date
  • SJ 11-24-2025
  • LPTX 11-12-2025
  • Dividend Yield
  • SJ N/A
  • LPTX N/A
  • EPS Growth
  • SJ N/A
  • LPTX N/A
  • EPS
  • SJ 0.04
  • LPTX N/A
  • Revenue
  • SJ $185,461,906.00
  • LPTX N/A
  • Revenue This Year
  • SJ N/A
  • LPTX N/A
  • Revenue Next Year
  • SJ N/A
  • LPTX N/A
  • P/E Ratio
  • SJ $14.19
  • LPTX N/A
  • Revenue Growth
  • SJ N/A
  • LPTX N/A
  • 52 Week Low
  • SJ $0.49
  • LPTX $0.22
  • 52 Week High
  • SJ $1.16
  • LPTX $4.79
  • Technical
  • Relative Strength Index (RSI)
  • SJ 40.37
  • LPTX 53.01
  • Support Level
  • SJ $0.50
  • LPTX $0.57
  • Resistance Level
  • SJ $0.54
  • LPTX $0.66
  • Average True Range (ATR)
  • SJ 0.05
  • LPTX 0.13
  • MACD
  • SJ 0.00
  • LPTX -0.01
  • Stochastic Oscillator
  • SJ 26.83
  • LPTX 29.57

About SJ Scienjoy Holding Corporation

Scienjoy Holding Corp is a provider of mobile live streaming platforms in China and focuses on interactive show live streaming from broadcasters to users. It operates a mobile live streaming business by which it provides live streaming entertainment from professional broadcasters to end-users, allowing for the operation of live social video communities. Using its mobile applications, users can select broadcasters and enter real-time video rooms to interact with them. In addition to the real-time interaction, users can also view photos posted by broadcasters in their personal pages, leave comments, and engage in private chats with broadcasters when such broadcasters are not streaming. In addition, users can also play simple, fun games using virtual currencies within the video rooms.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.

Share on Social Networks: